Show simple item record

dc.contributor.authorDepartment of Health (DoH)
dc.date.accessioned2015-08-20T10:51:53Zen
dc.date.available2015-08-20T10:51:53Zen
dc.date.issued2014-12en
dc.identifier.citationDepartment of Health,en
dc.identifier.urihttp://hdl.handle.net/10147/575348en
dc.descriptionThe role of this advisory group was to advise on the feasibility of a multiannual public health treatment plan for patients with hepatitis C infection based on clinical prioritisation criteria for identification of patients for each treatment phase.The Advisory group included patient advocates, clinicians, the National Centre for Pharmaco-economics (NCPE),HIQA,the HSE and officials from the Department of Health and is chaired by the CMO’s office After reviewing the evidence on clinical and cost effectiveness and the budget impact of the new drug regimens, the Group advised on the development of a treatment strategy. This treatment strategy’s implementation will over the next few years aim to increase the number of people with hepatitis C infection being treated effectively with complete clearance of the virus and reduce the numbers of people in the community with hepatitis C. Theimplementation of the treatment strategy is an important component in ultimately working towards eradication of hepatitis C in the Irish population.en
dc.language.isoenen
dc.publisherDepartment of Health (DoH)en
dc.subjectHEALTH SERVICES AND THEIR MANAGEMENTen
dc.subjectHEPATITIS Cen
dc.titlePublic health plan for the pharmaceutical treatment of hepatitis cen
dc.typeReporten
refterms.dateFOA2018-08-27T07:39:46Z


Files in this item

Thumbnail
Name:
Publichealthplanhepc.pdf
Size:
817.8Kb
Format:
PDF
Description:
Public Health plan Hep c

This item appears in the following Collection(s)

Show simple item record